Guidance for market authorization requirements for COVID-19 vaccines: Overview

Guidance for market authorization requirements for COVID-19 vaccines: Overview This document provides guidance to vaccine manufacturers seeking authorization for their vaccine that targets the SARS-CoV-2 virus. This guidance applies to applications under the interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19. 2022-07-28 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19SARS-CoV-2 virusCOVID-19 vaccinesCOVID-19 drugsmarket authorization requirementsvaccine manufacturersimportationsale and advertising Guidance for market authorization requirements for COVID-19 vaccines: OverviewHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization.html Guidance for market authorization requirements for COVID-19 vaccines: OverviewHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/autorisations.html

This document provides guidance to vaccine manufacturers seeking authorization for their vaccine that targets the SARS-CoV-2 virus. This guidance applies to applications under the interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19.

Data and Resources

Similar records